Development and Validation of the Blood Glucose Measurement Device by Air Analysis Expired

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT05207020

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05207020
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05207020. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-12-01 (actual); primary completion 2023-02-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Development and Validation of the Blood Glucose Measurement Device by Air Analysis Expired
Acronym
BOYDSENSE
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
Glycemia estimated by exhaled air analyzer
Intervention (Behavioral)
Questionnaire
Intervention (Biological)
Veinous glycemia
Intervention (Biological)
Capillary glycemia
Intervention (Biological)
constitution biological collection
Intervention (Biological)
Blood sample
Intervention (Other)
Test meal
Lead sponsor
University Hospital, Toulouse (class: other)

Record details

Record id
cardio:ct-nct05207020
Content hash
a5b26582db1e920ea658ea53ec314262c9a76973778057a220b5a6e8494ae522